Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 3/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.44 |
| ▸ | TOP2A | P11388 | 1/20 | 0.43 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.42 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12268893 | 0.96 | PDGFRB (0.48) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL15497847 | 0.94 | PDGFRB (0.54) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL15497834 | 0.91 | PDGFRB (0.51) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL17322716 | 0.88 | PDGFRB (0.49) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL16483100 | 0.88 | PDGFRB (0.54) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL15497848 | 0.83 | PDGFRB (0.46) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL16483283 | 0.82 | PDGFRB (0.62) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL16483088 | 0.82 | NPC1 (0.54) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD | |
| SCHEMBL12269100 | 0.82 | ERN1 (0.36) | PDGFRBPDGFRACYP2A6CYP1A2 | |
| SCHEMBL15891148 | 0.81 | CYP1A2 (0.44) | PDGFRBPDGFRACYP2A6BIRC5PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8021766-B2 | layer containing an organic compound sandwiched between the pair of electrodes; high color purity, high efficiency, high luminance, and a long life; nonaggregate; cost efficiency | CANON KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-8021766-B2 | layer containing an organic compound sandwiched between the pair of electrodes; high color purity, high efficiency, high luminance, and a long life; nonaggregate; cost efficiency | CANON KABUSHIKI KAISHA (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286611-A1 | BENZO(GHI)FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | GTF2I, FLI1, GLB1 | PDGFRB 841/4885PDGFRA 588/4885CYP2A6 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.